Concentrix (CNXC) reported Q2 2025 revenue of $2.42 billion, beating estimates of $2.38 billion and rising 1.68% year over year.
Adjusted earnings came in at $2.70 per share, slightly below the estimate of $2.75 and nearly flat compared to $2.69 per share a year ago.
During the regular trading session, CNXC opened at $55.94 and fluctuated between $54.24 and $56.34.
The stock saw a trading volume of 1.47 million shares throughout the day.
Concentrix revised its FY 2025 earnings outlook to a range of $11.53 to $11.76, compared with the prior $11.18 to $11.77 and slightly above the estimate of $11.54.
FY 2025 revenue guidance was raised to $9.72 billion to $9.82 billion from $9.49 billion to $9.63 billion, surpassing the estimate of $9.61 billion. For Q3 2025, Concentrix projects earnings between $2.80 and $2.91 per share versus an estimate of $2.90, while revenue is forecasted at $2.45 billion to $2.47 billion, above the $2.39 billion estimate.
